Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy
Clinical trial NCT03193047 · COMPLETED
Trial details
- NCT number
- NCT03193047
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-07
- Primary completion
- 2018-01-29
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.